259 related articles for article (PubMed ID: 14512803)
1. Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions.
Ahn WS; Yoo J; Huh SW; Kim CK; Lee JM; Namkoong SE; Bae SM; Lee IP
Eur J Cancer Prev; 2003 Oct; 12(5):383-90. PubMed ID: 14512803
[TBL] [Abstract][Full Text] [Related]
2. Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia.
Garcia FA; Cornelison T; Nuño T; Greenspan DL; Byron JW; Hsu CH; Alberts DS; Chow HH
Gynecol Oncol; 2014 Feb; 132(2):377-82. PubMed ID: 24388920
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.
Chow HH; Cai Y; Hakim IA; Crowell JA; Shahi F; Brooks CA; Dorr RT; Hara Y; Alberts DS
Clin Cancer Res; 2003 Aug; 9(9):3312-9. PubMed ID: 12960117
[TBL] [Abstract][Full Text] [Related]
4. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.
Chow HH; Hakim IA; Vining DR; Crowell JA; Ranger-Moore J; Chew WM; Celaya CA; Rodney SR; Hara Y; Alberts DS
Clin Cancer Res; 2005 Jun; 11(12):4627-33. PubMed ID: 15958649
[TBL] [Abstract][Full Text] [Related]
5. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
[TBL] [Abstract][Full Text] [Related]
6. Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial.
Stockfleth E; Beti H; Orasan R; Grigorian F; Mescheder A; Tawfik H; Thielert C
Br J Dermatol; 2008 Jun; 158(6):1329-38. PubMed ID: 18363746
[TBL] [Abstract][Full Text] [Related]
7. A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression.
Ahn WS; Huh SW; Bae SM; Lee IP; Lee JM; Namkoong SE; Kim CK; Sin JI
DNA Cell Biol; 2003 Mar; 22(3):217-24. PubMed ID: 12804120
[TBL] [Abstract][Full Text] [Related]
8. Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatotoxic: Phase I single group and phase II randomized placebo-controlled studies.
Lovera J; Ramos A; Devier D; Garrison V; Kovner B; Reza T; Koop D; Rooney W; Foundas A; Bourdette D
J Neurol Sci; 2015 Nov; 358(1-2):46-52. PubMed ID: 26298797
[TBL] [Abstract][Full Text] [Related]
9. A pilot study to evaluate the safety and efficacy of an oral dose of (-)-epigallocatechin-3-gallate-rich polyphenon E in patients with mild to moderate ulcerative colitis.
Dryden GW; Lam A; Beatty K; Qazzaz HH; McClain CJ
Inflamm Bowel Dis; 2013 Aug; 19(9):1904-12. PubMed ID: 23846486
[TBL] [Abstract][Full Text] [Related]
10. Modulation of human glutathione s-transferases by polyphenon e intervention.
Chow HH; Hakim IA; Vining DR; Crowell JA; Tome ME; Ranger-Moore J; Cordova CA; Mikhael DM; Briehl MM; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1662-6. PubMed ID: 17684143
[TBL] [Abstract][Full Text] [Related]
11. Lung cancer inhibitory effect of epigallocatechin-3-gallate is dependent on its presence in a complex mixture (polyphenon E).
Fu H; He J; Mei F; Zhang Q; Hara Y; Ryota S; Lubet RA; Chen R; Chen DR; You M
Cancer Prev Res (Phila); 2009 Jun; 2(6):531-7. PubMed ID: 19470785
[TBL] [Abstract][Full Text] [Related]
12. [Effects of green tea extract on expression of human papillomavirus type 16 oncoproteins-induced hypoxia-inducible factor-1alpha and vascular endothelial growth factor in human cervical carcinoma cells].
Tang XD; Zhou X; Zhang QZ; Le AD; Zhou KY
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2872-7. PubMed ID: 19080502
[TBL] [Abstract][Full Text] [Related]
13. The tea polyphenol, (-)-epigallocatechin gallate effects on growth, apoptosis, and telomerase activity in cervical cell lines.
Yokoyama M; Noguchi M; Nakao Y; Pater A; Iwasaka T
Gynecol Oncol; 2004 Jan; 92(1):197-204. PubMed ID: 14751158
[TBL] [Abstract][Full Text] [Related]
14. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability.
Lee MJ; Maliakal P; Chen L; Meng X; Bondoc FY; Prabhu S; Lambert G; Mohr S; Yang CS
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1025-32. PubMed ID: 12376503
[TBL] [Abstract][Full Text] [Related]
16. Green tea compound in chemoprevention of cervical cancer.
Zou C; Liu H; Feugang JM; Hao Z; Chow HH; Garcia F
Int J Gynecol Cancer; 2010 May; 20(4):617-24. PubMed ID: 20686382
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator.
Ho YC; Yang SF; Peng CY; Chou MY; Chang YC
J Oral Pathol Med; 2007 Nov; 36(10):588-93. PubMed ID: 17944751
[TBL] [Abstract][Full Text] [Related]
18. Green tea catechins are potent anti-oxidants that ameliorate sodium iodate-induced retinal degeneration in rats.
Yang Y; Qin YJ; Yip YW; Chan KP; Chu KO; Chu WK; Ng TK; Pang CP; Chan SO
Sci Rep; 2016 Jul; 6():29546. PubMed ID: 27383468
[TBL] [Abstract][Full Text] [Related]
19. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of the green tea derivative, EGCG, by the topical route of administration in mouse and human skin.
Dvorakova K; Dorr RT; Valcic S; Timmermann B; Alberts DS
Cancer Chemother Pharmacol; 1999; 43(4):331-5. PubMed ID: 10071985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
